Writing in the Conversation, Benjamin Land, a research associate professor of pharmacology at the University of Washington, explains how cannabis could be used as an opioid substitute.
Chris Hudalla, president and chief scientific officer at ProVerde Laboratories, explores the legality and implications of novel synthetic cannabinoids.
Genetec's Scott Thomas outlines the three security factors every entrepreneur should consider before opening their cannabis production facility.
Analytical Cannabis recently caught up with the minds behind Cannatrol to learn more about cannabis drying and the company's innovative approach to curing.
Heavy metals expert Robert Thomas explores how stainless steel equipment could pose a contamination risk in cannabis operations.
Morgan Keefer, an accreditation officer at A2LA, explains exactly why cannabis testing labs need ISO accreditation.
Don Bellamy, Chief Executive Officer of Linneo Health, looks at the impact medical cannabis regulation has had in the UK and considers what other countries could learn from it.
Martha Hernández, a scientist at CloudLIMS, breaks down the seven requirements anyone should consider before starting a cannabis extraction facility.